These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29108200)

  • 1. [Effect of transforming growth factor-β1 on HBV replication and antigen synthesis in HepG2.2.15 cells with steatosis].
    Wang Y; Zhao LF; Wang RR; Zhi SW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):732-737. PubMed ID: 29108200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of HBV on the expression of SREBP in the hepatocyte of chronic hepatitis B patients combined with hepatic fatty change].
    Jiang CY; Zeng WQ; Chen YX; Dai FH; Jiang P
    Zhonghua Gan Zang Bing Za Zhi; 2011 Aug; 19(8):608-13. PubMed ID: 22152319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.
    Hong MH; Chou YC; Wu YC; Tsai KN; Hu CP; Jeng KS; Chen ML; Chang C
    PLoS One; 2012; 7(1):e30360. PubMed ID: 22276183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
    Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid.
    Bai XP; Dong F; Yang GH; Zhang L
    Lipids Health Dis; 2019 Apr; 18(1):89. PubMed ID: 30954075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of transforming growth factor-β1 and HBx enhances hepatitis B virus replication and augments host immune cytokines and chemokines.
    Almajhdi FN; Al-Qudari AY; Hussain Z
    Ann Hepatol; 2013; 12(3):408-15. PubMed ID: 23619257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].
    Zhou YP; Wu R; Shen W; Yu HH; Yu SJ
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760
    [No Abstract]   [Full Text] [Related]  

  • 8. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease].
    He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY
    Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
    Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA.
    Chou YC; Chen ML; Hu CP; Chen YL; Chong CL; Tsai YL; Liu TL; Jeng KS; Chang C
    Hepatology; 2007 Sep; 46(3):672-81. PubMed ID: 17580335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutant of HBx (HBxDelta127) promotes hepatoma cell growth via sterol regulatory element binding protein 1c involving 5-lipoxygenase.
    Wang Q; Zhang WY; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2010 Mar; 31(3):367-74. PubMed ID: 20173757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
    Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
    Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
    Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
    Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
    Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
    Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
    Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    McPherson S; Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
    J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
    Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability.
    Yan C; Chen J; Chen N
    Sci Rep; 2016 Mar; 6():22640. PubMed ID: 26935028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.